Szívelégtelenség: nyitott vizsgálatok itt: Japán
25 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
No phaseToborozResearch participation
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Ageo, Bunkyō City, Gifu, Hidaka, Hiroshima, Kagoshima, Kamakura, Kawasaki, Kitakyushu, Koshigaya, Kumamoto, Kyoto, Minatoku, Mitaka, Nagoya, Niigata, Okayama, Ōsaka-sayama, Sapporo, Shinagawa-ku, Shizuoka, Suita, Tokyo, Toyoake, Tsukuba, Urasoe, Yamagata, Yokohama
- People
- 20 000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180Regiszter frissítve: 2026-11-04
1. fázisToborozTrial-stage medicine
A Study of LY3971297 in Participants With Heart Failure
- Where
- Kobe, Kyoto, Suita-Shi, Tsuchiura-shi
- Age
- 18 év to 65 év
- People
- 90 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07547540EU 2026-525663-40-00Regiszter frissítve: 2026-11-04
No phaseToborozResearch participation
ELEVATE-HFpEF Clinical Study
- Where
- Chiba, Kitakyushu, Suita
- Age
- 40 év and over
- People
- 700 worldwide
- Run by
- Medtronic Cardiac Rhythm and Heart Failure
See details and how to joinNCT06678841Regiszter frissítve: 2026-11-03
2. fázisToborozTrial-stage medicine
The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial)
- Where
- Nagoya, Ōbu, Tokyo, Tsu
- Age
- 26 év and over
- People
- 90
- Run by
- Nagoya University
See details and how to joinNCT07855692Regiszter frissítve: 2026-10-30
3. fázisToborozTrial-stage medicine
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Chiba, Fujinomiya-shi, Fukuoka, Hachioji-shi, Hamamatsu, Higashiyamato-shi, Himeji-Shi, Kagoshima, Kanazawa, Kitaazumi-gun, Kitakyushu-shi, Kumamoto, Kyoto, Niigata, Ōita, Sagamihara-shi, Sapporo, Shinagawa-ku, Suginami-ku, Suita-shi, Takamatsu, Takarazuka-shi, Toyoake-shi, Yonago-shi
- Age
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459Regiszter frissítve: 2026-10-29
3. fázisToborozTrial-stage medicine
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Where
- Aichi, Kasugai, Azumino-shi, Chiba, Chiba, Chūōku, Fujisawa-shi, Fukuoka, Kitakyushu, Hachioji-shi, Hamada-Shi, Higashiibaraki-gun, Himeji-Shi, Hiratsuka-shi, Hokkaido, Sapporo, Hokkaido, Tomakomai, Hyogo, Amagasaki, Ikeda-cho, Kitaazumi, Ishikawa, Kanazawa, Iwakuni-shi, Kamakura-shi, Kanagawa, Miura-gun, Kanagawa, Yokohama, Kanonji-shi, Kawanishi-shi, Kishiwada-shi, Kobe, Kumamoto, Matsumoto-shi, Matsuyama, Mito, Nakano-shi, Ōita, Okayama, Okayama, Okinawa, Naha, Okinawa, Urasoe, Osaka, Osaka, Osaka, Saga, Saitama-shi, Sendai, Suita-shi, Tachikawa-shi, Takamatsu, Tokushima, Tokyo, Ome, Tomakomai-shi
- Age
- 18 év and over
- People
- 6712 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06424288EU 2023-509706-30-00Regiszter frissítve: 2026-10-28
3. fázisToborozTrial-stage medicine
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Where
- Amagasaki-shi, Asahi-shi, Fujisawa-shi, Fukuoka, Fukuoka, Chikushino, Gunma, Maebashi, Hachioji-shi, Hamada-Shi, Hamamatsu, Himeji-Shi, Hiratsuka-shi, Hitachi-Naka, Ishikawa, Kanazawa, Iwakuni-shi, Kamakura-shi, Kanagawa, Miura-gun, Kanonji-shi, Kasama-Shi, Kasugai-shi, Kawaguchi-shi, Kawasaki-shi, Kishiwada-shi, Kobe, Kumamoto, Kure, Matsudo-shi, Matsumoto-shi, Matsuyama, Meguro-Ku, Mito, Miyagi, Sendai, Nagasaki, Nagasaki, Nagoya, Nakano-shi, Nara, Kashihara, Okayama, Okayama, Ome-shi, Omura-shi, Osaka, Saitama, Saitama, SakaiShi, Sapporo, Sendai, Shimonoseki-shi, Suita-shi, Suita-Shi, Tachikawa-shi, Takasaki-shi, Tanabe-shi, Tokushima, Tomakomai-shi, Toyota-shi, Ueda-shi
- Age
- 18 év and over
- People
- 4200 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06935370EU 2024-519525-38-00Regiszter frissítve: 2026-10-28
2. fázisToborozTrial-stage medicine
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Where
- Iwakuni, Kasugai, Kishiwada, Kodaira-shi, Koga, Matsudo, Meguro-Ku, Nagasaki, Sagamihara, Sapporo, Sendai, Suginami, tabashi City, Toshimaku, Tsu, Wako, Yokohama
- Age
- 18 év to 79 év
- People
- 620 worldwide
- Run by
- Pfizer
See details and how to joinNCT06991257EU 2024-518438-94-00Regiszter frissítve: 2026-10-23
1/2. fázisToborozTrial-stage medicine
Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)
- Where
- Kawasaki, Matsumoto, Shinagawa Ku, Shinjuku-ku, Tsukuba
- Age
- 20 év to 80 év
- People
- 14
- Run by
- Heartseed Inc.
See details and how to joinNCT07347197Regiszter frissítve: 2026-10-22
3. fázisToborozTrial-stage medicine
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Where
- Amagasaki-shi, Asahikawa-shi, Azumino-shi, Chūōku, Fukui-shi, Hakusan-shi, Himeji, Izumo-shi, Kakegawa-shi, Kamakura-shi, Kanazawa, Kawaguchi-shi, Kishiwada-shi, Kita-ku, Kyoto, Matsudo-shi, Meguro-ku, Mito, Miyazaki, Nagano, Ogaki-shi, Ōita, Ōmihachiman, Osaka, Saitama-shi, Sendai, Shizuoka, Suita-shi, tabashi City, Takamatsu, Takatsuki-shi, Toyota-Shi, Tsuchiura-shi, Ueda-shi, Uwajima-shi, Yanagawa-shi, Yokkaichi-shi, Yokohama
- Age
- 40 év and over
- People
- 11 300 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06677060EU 2024-514506-32-00Regiszter frissítve: 2026-10-21
3. fázisToborozTrial-stage medicine
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- Where
- Amagasaki, Bunkyo-ku, Fukuoka, Himeji, Kanagawa, Kashihara, Kitakyushu, Kobe, Kumamoto, Kurume-shi, Kyoto, Matsumoto, Nagasaki, Nagoya, Nankoku-shi, Osaka, Sapporo, Suita, Tokyo, Toyama, Tsu, Uwajima-shi, Yamaguchi Prefecture, Yokohama
- Age
- 18 év and over
- People
- 1280 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07207811Regiszter frissítve: 2026-10-21
2. fázisToborozTrial-stage medicine
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
- Where
- Kamakura, Kasugai, Matsubara, Matsudo
- Age
- 18 év to 80 év
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07830719EU 2026-525974-21-00Regiszter frissítve: 2026-10-15
3. fázisToborozResearch participation
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Beppu-shi, Bunkyō City, Fujisawa-shi, Fukui-shi, Fukuoka, Fukutsu-shi, Hakusan-shi, Higashiibaraki-gun, Himeji, Iwakuni-shi, Kanazawa, Kanonji-shi, Kasugai-shi, Kasuga-shi, Kawaguchi, Kawanishi-shi, Kishiwada-shi, Kitakyusyu-shi, Kobe, Kochi, Kure-shi, Maebashi, Matsumoto-shi, Meguro-ku, Mito, Moriyama-shi, Nagoya, Ōita, Osaka, Sagamihara-shi, Saitama-shi, Sakaishi, Sakata, Sanyoonoda-shi, Toshima-ku, Toyota, Tsuchiura-shi, Ueda-shi, Uji-shi, Uwajima-shi, Yanagawa-shi, Yokohama
- Age
- 18 év to 130 év
- People
- 3850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652EU 2023-508162-15-00Regiszter frissítve: 2026-10-13
2. fázisToborozTrial-stage medicine
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Where
- Bunkyo-ku, Tokyo, Chikushino-shi, Fukuoka, Himeji-shi, Hyogo, Ibaraki, Kagawa, Kanagawa, Kita-gun, Kagawa, Kobe-shi, Hyogo, Ome-shi, Tokyo, Osaka-shi, Osaka, Osaka-Shi, Osaka, Sapporo-shi, Hokkaido, Yokohama-shi, Kanagawa
- Age
- 40 év to 84 év
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06979362EU 2024-515796-35-00Regiszter frissítve: 2026-10-05
3. fázisToborozTrial-stage medicine
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Where
- Aomori, Chikushino-shi, Chūōku, Fukui-shi, Fukushima, Higashiibaraki-gun, Higashiohmi-shi, Iwakuni-shi, Kagoshima, Kamakura-shi, Kanazawa, Kashihara-shi, Kasugai-shi, Kawagoe-shi, Kishiwada-shi, Kitakyusyu-shi, Kobe, Kure-shi, Kyoto, Maebashi, Matsusaka-shi, Minatoku, Mito, Morioka, Nagasaki, Nagoya, Ōmihachiman, Osaka, Sagamihara-shi, Sapporo, Sayama-shi,, Sendai, Shibuya-ku, Shizuoka, Suginami City, Suita, Suzuka-shi, Tachikawa-shi, Takaoka-shi, Takatsuki-shi, Tokushima, Toshima-ku, Toyama, Ueda-shi, Urasoe-Shi, Urayasu-shi, Uruma, Utsunomiya, Wakayama, Yakushi, Yokohama
- Age
- 18 év and over
- People
- 6950 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07761117EU 2026-526304-79-00Regiszter frissítve: 2026-09-28
No phaseToborozResearch participation
Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
- Where
- Nagoya, Tōon
- Age
- 18 év and over
- People
- 400 worldwide
- Run by
- Oslo University Hospital
See details and how to joinNCT07436299Regiszter frissítve: 2026-09-10
3. fázisToborozTrial-stage medicine
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Bunkyo-ku, Tokyo, Chiba-shi,Chiba, Chikushino-shi, Fukuoka, Fuchu-shi,Tokyo, Fukuoka-shi, Fukuoka, Higashiosaka-shi, Osaka, Himeji-shi, Hyogo, Hyōgo, Ibaraki, Kanagawa, Kasugai-shi, Aichi, Kofu-shi, Yamanashi, Kyoto-shi, Kyoto, Maebashi-shi, Gunma, Matsumoto-shi, Nagano, Miura-gun, Kanagawa, Morioka-shi, Iwate, Nagasaki, Osaka, Osaka-Shi, Osaka, Ota-shi, Gunma, Sapporo-shi, Hokkaido, Shinjuku-ku, Tokyo, Shizuoka, Takamatsu-shi, Kagawa, Tokyo, Tomakomai-Shi, Hokkaido, Toshima-ku,Tokyo, Uwajima-shi, Wakayama-shi, Wakayama, Yokohama-shi，Kanagawa
- Age
- 18 év and over
- People
- 5610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001EU 2025-523717-29-00Regiszter frissítve: 2026-08-18
4. fázisToborozTrial-stage medicine
Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
- Where
- Fukuoka, Handa, Iizuka, Izunokuni, Kakegawa, Kawagoe, Maebashi, Nagoya, Ōbu, Osaka, Sagamihara, Sakai, Sapporo, Suita, Takasaki, Tokyo, Tōon, Toyota
- Age
- 18 év and over
- People
- 550
- Run by
- Juntendo University
See details and how to joinNCT07397650Regiszter frissítve: 2026-08-10
3. fázisToborozTrial-stage medicine
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- Where
- Isehara, Iwakuni, Kyoto, Osaka, Ōta-ku, Sagamihara, Sapporo, Sendai, Suita
- Age
- 18 év and over
- People
- 2600 worldwide
- Run by
- Colorado Prevention Center
See details and how to joinNCT06033950Regiszter frissítve: 2026-07-10
No phaseToborozResearch participation
A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions
- Where
- Multiple Locations
- People
- 1400
- Run by
- Bayer
See details and how to joinNCT05666518Regiszter frissítve: 2026-07-06
2. fázisToborozTrial-stage medicine
Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG
- Where
- Osaka
- Age
- 18 év to 80 év
- People
- 50
- Run by
- Rohto Pharmaceutical Co., Ltd.
See details and how to joinNCT07192211Regiszter frissítve: 2026-06-09
No phaseToborozResearch participation
Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)
- Where
- Akita, Bunkyo Ku, Fuchū, Fukuoka, Hamamatsu, Hidaka, Kawasaki, Kumamoto, Kurume, Nagasaki, Ōbu, Okayama, Ōmura, Ōta-ku, Saitama, Sapporo, Setagaya-ku, Shinagawa Ku, Shinjuku Ku, Toyama, Toyoake, Tsu, Tsukuba, Yokohama
- Age
- 1 év to 17 év
- People
- 30
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06659393Regiszter frissítve: 2026-04-13
2. fázisToborozTrial-stage medicine
A Research Study Comparing CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Reduced/Mildly Reduced Ejection Fraction and Left Ventricular Hypertrophy
- Where
- Bunkyo-ku, Tokyo, Hamamatsu-shi, Shizuoka, Himeji-shi, Hyogo, Ibaraki, Kanagawa, Kita-gun, Kagawa, Kobe-shi, Hyogo, Osaka, Osaka-shi, Osaka, Osaka-Shi, Osaka, Sapporo-shi, Hokkaido, Yokohama-shi, Kanagawa
- Age
- 40 év to 84 év
- People
- 200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06979375EU 2024-515797-27-00Regiszter frissítve: 2026-03-11
3. fázisToborozTrial-stage medicine
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
- Where
- Adachi City, Anjo, Chikushino-shi, Chiyoda City, Fuchū, Fukuoka, Funabashi, Gifu, Hachiōji, Hamamatsu, Hirosaki, Hiroshima, Hokkaido, Isehara, Izunokuni, Kamakura, Kamogawa, Kanagawa, Kashihara, Kasukabe, Kawagoe, Kawaguchi, Kawasaki, Kochi, Kurume, Kushiro, Maebashi, Minato, Morioka, Nagakute, Nagoya, Nankoku, Nara, Ōgaki, Okayama, Okinawa, Osaka, Saitama, Sapporo, Sayama, Shinjuku, Sōka, Suita, Sumoto, Tachikawa, Tokushima, Tokyo, Tsuchiura, Urasoe, Urayasu, Utsunomiya, Yokohama
- Age
- 20 év and over
- People
- 444
- Run by
- Juntendo University
See details and how to joinNCT05392764Regiszter frissítve: 2026-02-13
No phaseCsak meghívásosResearch participation
A Prognostic Study for Patients With Cardiovascular Disease in Niigata
- Where
- Niigata
- Age
- 18 év and over
- People
- 8500
- Run by
- Niigata University Medical & Dental Hospital
See details and how to joinNCT06992284Regiszter frissítve: 2025-05-28
Minden vizsgálat (Szívelégtelenség) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.